lupus erythematosus
Information
- Disease name
- lupus erythematosus
- Disease ID
- DOID:8857
- Description
- "An autoimmune disease that is characterized by a constellation of findings that include elevated antibodies to nuclear antigens, antiphospholipids, low complement levels, ulcers, non-scarring alopecia, renal or neurologic damage, and low white blood cell and platelet counts, has_symptom rashes, fatigue, arthritis, hair loss, seizures, and symptoms related to affected organs." [url:https\://www.ncbi.nlm.nih.gov/pubmed/29366725]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04128579 | Completed | Phase 1 | Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis | October 1, 2019 | January 18, 2024 |
| NCT00029926 | Completed | Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity | January 2002 | November 2002 | |
| NCT01516788 | Completed | N/A | Photoprovocation Testing in Subjects With Cutaneous Lupus | December 2011 | July 2, 2018 |
| NCT01686555 | Completed | Phase 1 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE) | November 2012 | June 2015 |
| NCT01904812 | Completed | N/A | Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus | December 2011 | May 2015 |
| NCT05945784 | Completed | Exploring Accessible Beauty for Individuals With Upper Extremity Deficits | July 21, 2023 | September 29, 2023 | |
| NCT02455089 | Completed | N/A | Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus | June 2015 | February 2019 |
| NCT02747277 | Completed | Analysis of B Cells From Autoimmune Individuals | May 2016 | January 2022 | |
| NCT05921058 | Completed | Phase 1/Phase 2 | The Effects of Mesenchymal Stem Cell Secretome in Lupus Patients | August 1, 2022 | March 9, 2023 |
| NCT03098823 | Completed | Phase 4 | A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE | September 12, 2017 | June 15, 2020 |
| NCT05098600 | Completed | The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic | October 15, 2021 | December 20, 2022 | |
| NCT03253666 | Completed | Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component) | January 2017 | May 2018 | |
| NCT03421184 | Completed | N/A | Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus | November 26, 2018 | June 26, 2023 |
| NCT03504540 | Completed | Comparison of Complement Factors and Genetic Polymorphisms of AMD Between Patients With Systemic Lupus Erythematosus (SLE) With and Without Retinal "Pseudo-drusen-like" Deposits: Case-control Study (PL-AMD) | April 5, 2018 | May 15, 2021 | |
| NCT04089930 | Completed | Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients | June 1, 2020 | October 1, 2023 | |
| NCT05097365 | Enrolling by invitation | N/A | Methyl-donor Nutrient Supplementation and Methylation Profile in Lupus Patients With Obesity | January 1, 2022 | December 31, 2026 |
| NCT06426316 | Not yet recruiting | N/A | The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology. | May 15, 2024 | April 30, 2027 |
| NCT01266915 | Recruiting | Cutaneous Lupus Registry | January 2009 | December 2025 | |
| NCT03543839 | Recruiting | Phase 4 | Trial of Belimumab in Early Lupus | September 15, 2020 | December 2026 |
| NCT05251415 | Recruiting | Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases | April 4, 2022 | April 4, 2032 | |
| NCT05545839 | Recruiting | N/A | Transition to Adulthood Through Coaching and Empowerment in Rheumatology | October 17, 2022 | April 2025 |
| NCT06041568 | Recruiting | Phase 1 | A Study of Imvotamab in Severe Systemic Lupus Erythematosus | August 15, 2023 | May 2026 |
| NCT06072287 | Recruiting | The Living With a Long-Term Condition Study | June 28, 2023 | January 10, 2024 | |
| NCT06161363 | Recruiting | Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus | November 29, 2023 | May 28, 2024 | |
| NCT06294236 | Recruiting | Phase 1 | Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) | April 29, 2024 | March 2028 |
| NCT03840928 | Recruiting | PatientSpot Formerly Known as ArthritisPower | April 1, 2015 | March 1, 2025 | |
| NCT03673748 | Recruiting | Phase 2 | Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells | December 27, 2022 | July 2026 |
| NCT02080195 | Terminated | Phase 1/Phase 2 | Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE) | September 13, 2016 | March 29, 2017 |
| NCT04018222 | Unknown status | Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic | May 31, 2019 | December 31, 2020 | |
| NCT02891213 | Unknown status | Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus. | November 2016 | October 2017 | |
| NCT03562065 | Unknown status | Phase 1/Phase 2 | Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord | September 11, 2019 | June 1, 2024 |
| NCT04213690 | Unknown status | A Pilot Study to Explore the Role of Gut Flora in Lupus | March 2, 2020 | July 2023 | |
| NCT04449653 | Unknown status | Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals | April 28, 2020 | June 1, 2021 | |
| NCT03913754 | Unknown status | Psycho-social Consequences of Systemic Lupus Erythematosus | June 30, 2019 | July 1, 2021 | |
| NCT03142412 | Unknown status | Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization | April 17, 2017 | October 17, 2021 |
- Disase is a (Disease Ontology)
- DOID:417
- Cross Reference ID (Disease Ontology)
- ICD10CM:L93
- Cross Reference ID (Disease Ontology)
- ICD9CM:695.4
- Cross Reference ID (Disease Ontology)
- NCI:C27153
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:200936003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0409974
- Exact Synonym (Disease Ontology)
- lupus
- ICD10 preferred id (Insert disease from ICD10)
- D0009987
- ICD10 class code (Insert disease from ICD10)
- L93